---

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Revenue: $20.1 billion (2014)
Employees: circa 18,000

In 2006, Robert joined Amgen as Vice President, Operations Strategy. He was appointed to the Amgen Board of Directors in October 2011, and became Chairman in January 2013 and CEO in May 2012. Before Amgen, he was a managing director at Morgan Stanley in London where he held responsibility for the firm’s banking department and corporate finance activities in Europe.

www.amgen.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015